Ocular Therapeutix, Inc. - Common Stock (NQ:OCUL)

6.960 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ocular Therapeutix, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

NICE Posts Upbeat Earnings, Joins FTI Consulting, NVIDIA, Moderna And Other Big Stocks Moving Higher On Thursday ↗

February 22, 2024

U.S. stocks were higher, with the Nasdaq Composite gaining more 2% on Thursday.

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 22, 2024

Via Benzinga

SPS Commerce Posts Upbeat Results, Joins Masonite International, Impinj And Other Big Stocks Moving Higher On Friday ↗

February 09, 2024

U.S. stocks traded mixed, with the Nasdaq Composite gaining around 100 points on Friday. Shares of SPS Commerce, Inc. (NASDAQ: SPSC) rose sharply during Friday’s session following upbeat results.

Via Benzinga

Topics Stocks

What Happened To Ocular Therapeutix Stock After-Hours? ↗

December 13, 2023

Ocular Therapeutix, Inc. (NASDAQ: OCUL) shares are trading lower in Wednesday's after-hours session.

Via Benzinga

Recap: Ocular Therapeutix Q3 Earnings ↗

November 07, 2023

Via Benzinga

Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

February 09, 2024

Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) fell sharply during Friday’s session following third-quarter results.

Via Benzinga

Wall Street Thinks These 2 Biotech Stocks Could Soar in 2024 ↗

January 03, 2024

These two biotech stocks sport notable 12-month price targets. However, they are also uber-risky.

Via The Motley Fool

Why Nxu Shares Are Trading Higher By Around 42%; Here Are 20 Stocks Moving Premarket ↗

December 14, 2023

Shares of Nxu, Inc. (NASDAQ: NXU) rose sharply in pre-market trading after the company signed a letter of intent outlining investment in Lynx Motors. Nxu, shares rose 42.1% to $0.0278 in pre-market...

Via Benzinga

A Preview Of Ocular Therapeutix's Earnings ↗

August 04, 2023

Via Benzinga

5 Analysts Have This to Say About Ocular Therapeutix ↗

June 13, 2023

Via Benzinga

Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

December 14, 2023

Shares of Amtech Systems, Inc. (NASDAQ: ASYS) shares fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 14, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

December 14, 2023

It's time to start the day off right with a look at the biggest pre-market stock movers to watch for Thursday morning!

Via InvestorPlace

Expert Ratings for Ocular Therapeutix ↗

May 09, 2023

Via Benzinga

What 5 Analyst Ratings Have To Say About Ocular Therapeutix ↗

April 21, 2023

Via Benzinga

Adobe Issues Weak Forecast, Joins Mueller Water Products, AerSale And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

December 14, 2023

U.S. stock futures were higher this morning, with the Dow Jones futures gaining around 70 points on Thursday. Shares of Adobe Inc. (NASDAQ: ADBE) shares moved lower in pre-market trading following the...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 13, 2023

Via Benzinga

Top 5 Health Care Stocks That Are Ticking Portfolio Bombs ↗

December 05, 2023

As of Dec. 5, 2023, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Via Benzinga

Week In Review: Everest Acquires Novel Autoimmune Therapy In $132 Million Agreement ↗

September 23, 2023

Shanghai Everest Medicines acquired China/Asian rights to a novel therapy for autoimmune diseases from Kezar Life Sciences of South San Francisco in a deal worth $132.5 million. The company will make...

Via Talk Markets

Looking Into Ocular Therapeutix's Return On Capital Employed ↗

March 09, 2023

Via Benzinga

The Latest Analyst Ratings for Ocular Therapeutix ↗

March 07, 2023

Via Benzinga

Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

December 04, 2023

Shares of U Power Limited (NASDAQ: UCAR) shares moved lower during Monday’s session after the company announced pricing of registered follow-on offering of 10 million units at a purchase price of $1.20...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 14, 2023

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 09, 2023

Via Benzinga

Why MIND Technology Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

June 14, 2023

Gainers WeTrade Group, Inc. (NASDAQ: WETG) shares climbed 140.3% to $20.28. WeTrade launched large-scale language processing models to increase product applications in the field of artificial...

Via Benzinga

R&D Activities for Treating Dry Eye Syndrome Resulting in Promising Pipeline of Treatments

May 02, 2023

EQNX::TICKER_START (NASDAQ:OKYO),(NYSE:NVS),(NASDAQ:ALDX),(NASDAQ:OCUL),(NASDAQ:EYPT) EQNX::TICKER_END

Via FinancialNewsMedia

Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2023 ↗

April 21, 2023

Via Benzinga

OKYO Pharma Management Takes Company Stock In Private Placement Instead Of Deferred Pay ↗

April 18, 2023

Drug development can be notoriously slow, and it can take some companies 10 years or more to pass through all the trials and tests required by the Food and Drug Administration (FDA).

Via Benzinga

OKYO Pharma To Begin Phase 2 Efficacy Trials For Dry Eye Disease Drug Candidate In March 2023, Anticipates Releasing Topline Results By Q4 ↗

March 28, 2023

Drug development isn’t known for being fast-paced, and developing any new drug is generally a long process. However, OKYO Pharma Ltd. (NASDAQ: OKYO) is moving quickly to develop its eye treatment drug,...

Via Benzinga

Dick's Sporting Goods, WW International, Sea Limited And Other Big Stocks Moving Higher On Tuesday ↗

March 07, 2023

U.S. stocks traded lower, with the Dow Jones dropping around 150 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.